CFHR5

complement factor H related 5
OMIM: 608593, Gene2Phenotype

6 panels

Panel Reviews Mode of inheritance Details
6 panels
Green CFHR5 in COVID-19 research


Level 2: Viral research
Version 1.146

review BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • IUIS Classification February 2018
  • IUIS Classification December 2019
  • London North GLH
  • NHS GMS
  • GRID V2.0
  • North West GLH
  • Victorian Clinical Genetics Services
  • IUIS Classification December 2019
  • North West GLH
  • London North GLH
  • NHS GMS
  • IUIS Classification February 2018
  • Victorian Clinical Genetics Services
  • GRID V2.0
Phenotypes
  • Atypical hemolytic-uremic syndrome with anti-factor H antibodies
  • Atypical hemolytic uremic syndrome susceptibility
  • Nephropathy due to CFHR5 deficiency, 614809
  • Complement Deficiencies
  • Older onset atypical hemolytic-uremic syndrome, disseminated neisserial infections
Green CFHR5 in Membranoproliferative glomerulonephritis including C3 glomerulopathy


Level 2: Renal
Version 3.8
Latest signed off version: v3.6 (30 Apr 2025)

Component of the following Super Panels:

  • Unexplained young onset end-stage renal disease
  • review MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
    Sources
    • Expert Review Green
    • NHS GMS
    • Expert list
    Phenotypes
    • C3 glomerulopathy
    • C3G
    • Immune complex MPGN
    • IC-MPGN
    • Nephropathy due to CFHR5 deficiency, OMIM:614809
    • Immune-complex-mediated MPGN
    • CFHR5 nephropathy
    • Haematuria
    • Chronic Kidney Disease
    • Proteinuria
    • End stage renal disease
    Tags
    • currently-ngs-unreportable
    Amber CFHR5 in Atypical haemolytic uraemic syndrome


    Level 2: Renal
    Version 3.8
    Latest signed off version: v3.6 (30 Apr 2025)

    Component of the following Super Panels:

  • Unexplained young onset end-stage renal disease
  • review MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
    Sources
    • Expert Review Amber
    • Expert list
    Phenotypes
    • Nephropathy due to CFHR5 deficiency, MIM# 614809
    Red CFHR5 in Primary immunodeficiency or monogenic inflammatory bowel disease


    Level 2: Immunology
    Version 8.78
    Latest signed off version: v8.0 (30 Apr 2025)

    review BOTH monoallelic and biallelic, autosomal or pseudoautosomal
    Sources
    • Expert Review Red
    • IUIS Classification December 2019
    • North West GLH
    • London North GLH
    • NHS GMS
    • IUIS Classification February 2018
    • Victorian Clinical Genetics Services
    • GRID V2.0
    Phenotypes
    • Complement Deficiencies
    • Older onset atypical hemolytic-uremic syndrome, disseminated neisserial infections
    • Nephropathy due to CFHR5 deficiency, 614809
    • Atypical hemolytic-uremic syndrome with anti-factor H antibodies
    • Atypical hemolytic uremic syndrome susceptibility
    Green CFHR5 in Unexplained kidney failure in young people

    Level 3: Disorders of function
    Level 2: Renal and urinary tract disorders
    Version 1.124

    review MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
    Sources
    • Expert Review Green
    • Expert Review
    • Literature
    Phenotypes
    • C3 glomerulopathy
    • C3G
    • Immune complex MPGN
    • IC-MPGN
    • Nephropathy due to CFHR5 deficiency, OMIM:614809
    • Immune-complex-mediated MPGN
    • CFHR5 nephropathy
    • Haematuria
    • Chronic Kidney Disease
    • Proteinuria
    • End stage renal disease
    Amber CFHR5 in Haematuria


    Level 2: Renal
    Version 2.17
    Latest signed off version: v2.15 (30 Apr 2025)

    Component of the following Super Panels:

  • Unexplained young onset end-stage renal disease
  • review MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
    Sources
    • Expert Review Amber
    • NHS GMS
    • Expert Review
    • Literature
    Phenotypes
    • Nephropathy due to CFHR5 deficiency OMIM:614809